John D. Clements
14Patents
9h-index
17Co-inventors
69Inventor score
Filing activity: Jun 3, 1982 → May 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4808700A | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers | Emerging Cross-Sectional Technologies | 48 | Expired |
| US6033673A | Double mutant enterotoxin for use as an adjuvant | Emerging Cross-Sectional Technologies | 38 | Expired |
| US4411888A | Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6440423B1 | Mutant enterotoxin effective as a non-toxic oral adjuvant | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6019982A | Mutant enterotoxin effective as a non-toxic oral adjuvant | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6395964B1 | Oral immunization with transgenic plants | Human Necessities | 16 | Expired |
| US5308835A | Production of the E. coli LT-B enterotoxin subunit | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6413523B1 | Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5079165A | Production of the E. coli LT-B enterotoxin subunit in S. typhi | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6436407B1 | Mutant enterotoxin effective as a non-toxic adjuvant | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7063852B2 | Hybrid LT-A/CT-B holotoxin for use as an adjuvant | Emerging Cross-Sectional Technologies | 2 | Expired |
| US10472647B2 | Primary mesenchymal stem cells as a vaccine platform | Emerging Cross-Sectional Technologies | 1 | Active |
| US10166279B2 | Vaccine | Emerging Cross-Sectional Technologies | 0 | Active |
| US12337025B2 | Mutated e. coli enterotoxins as anti-inflammatory agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.